25 XP   0   0   10

Megasoft Limited
Buy, Hold or Sell?

Let's analyse Megasoft together

PenkeI guess you are interested in Megasoft Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Megasoft Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Megasoft Limited

I send you an email if I find something interesting about Megasoft Limited.

Quick analysis of Megasoft (30 sec.)










What can you expect buying and holding a share of Megasoft? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR26.21
Expected worth in 1 year
INR31.00
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
INR4.79
Return On Investment
10.0%

For what price can you sell your share?

Current Price per Share
INR48.05
Expected price per share
INR38.55 - INR57.50
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Megasoft (5 min.)




Live pricePrice per Share (EOD)

INR48.05

Intrinsic Value Per Share

INR10.09 - INR79.30

Total Value Per Share

INR36.30 - INR105.51

2. Growth of Megasoft (5 min.)




Is Megasoft growing?

Current yearPrevious yearGrowGrow %
How rich?$23.1m$22.1m$1m4.6%

How much money is Megasoft making?

Current yearPrevious yearGrowGrow %
Making money$1.3m$554.5k$822.8k59.7%
Net Profit Margin582.4%8.8%--

How much money comes from the company's main activities?

3. Financial Health of Megasoft (5 min.)




4. Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry (5 min.)




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Megasoft? (5 min.)

Welcome investor! Megasoft's management wants to use your money to grow the business. In return you get a share of Megasoft.

What can you expect buying and holding a share of Megasoft?

First you should know what it really means to hold a share of Megasoft. And how you can make/lose money.

Speculation

The Price per Share of Megasoft is INR48.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Megasoft.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Megasoft, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR26.21. Based on the TTM, the Book Value Change Per Share is INR1.20 per quarter. Based on the YOY, the Book Value Change Per Share is INR5.81 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Megasoft.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.010.0%0.010.0%0.010.0%0.010.0%0.000.0%
Usd Book Value Change Per Share0.010.0%0.010.0%0.070.1%0.020.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.010.0%0.070.1%0.020.0%0.000.0%
Usd Price Per Share0.27-0.27-0.62-0.23-0.17-
Price to Earnings Ratio18.46-18.46-82.13-69.38-55.72-
Price-to-Total Gains Ratio18.46-18.46-8.86-24.03-16.79-
Price to Book Ratio0.84-0.84-2.06-0.81-0.66-
Price-to-Total Gains Ratio18.46-18.46-8.86-24.03-16.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.5766
Number of shares1734
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.010.02
Gains per Quarter (1734 shares)24.9132.75
Gains per Year (1734 shares)99.62131.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10100900131121
201991900262252
302992900393383
403983900524514
504984900655645
605985900786776
706976900917907
80797790010481038
90897890011791169
100996990013101300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.01.00.093.3%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%9.06.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.014.06.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%9.06.00.060.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Megasoft

About Megasoft Limited

Megasoft Limited engages in the research and development, production, distribution, and sale of chemicals and pharmaceutical products. It intends to pursue in defense and manufacturing areas. The company was founded in 1994 and is based in Hyderabad, India.

Fundamental data was last updated by Penke on 2023-11-22 13:21:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Megasoft Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Megasoft earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 582.4% means that ₹5.82 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Megasoft Limited:

  • The MRQ is 582.4%. The company is making a huge profit. +2
  • The TTM is 582.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ582.4%TTM582.4%0.0%
TTM582.4%YOY8.8%+573.5%
TTM582.4%5Y119.2%+463.1%
5Y119.2%10Y60.8%+58.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ582.4%1.6%+580.8%
TTM582.4%1.8%+580.6%
YOY8.8%2.3%+6.5%
5Y119.2%1.7%+117.5%
10Y60.8%2.5%+58.3%
1.1.2. Return on Assets

Shows how efficient Megasoft is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • 3.0% Return on Assets means that Megasoft generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Megasoft Limited:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.0%0.0%
TTM3.0%YOY1.6%+1.4%
TTM3.0%5Y1.1%+1.9%
5Y1.1%10Y0.9%+0.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%0.1%+2.9%
TTM3.0%0.1%+2.9%
YOY1.6%0.3%+1.3%
5Y1.1%0.3%+0.8%
10Y0.9%0.5%+0.4%
1.1.3. Return on Equity

Shows how efficient Megasoft is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • 5.9% Return on Equity means Megasoft generated ₹0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Megasoft Limited:

  • The MRQ is 5.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.9%TTM5.9%0.0%
TTM5.9%YOY2.5%+3.4%
TTM5.9%5Y2.1%+3.8%
5Y2.1%10Y1.6%+0.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%0.6%+5.3%
TTM5.9%0.8%+5.1%
YOY2.5%0.7%+1.8%
5Y2.1%0.6%+1.5%
10Y1.6%1.0%+0.6%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Megasoft Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Megasoft is operating .

  • Measures how much profit Megasoft makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 1,081.9% means the company generated ₹10.82  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Megasoft Limited:

  • The MRQ is 1,081.9%. The company is operating very efficient. +2
  • The TTM is 1,081.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ1,081.9%TTM1,081.9%0.0%
TTM1,081.9%YOY27.5%+1,054.4%
TTM1,081.9%5Y230.0%+851.9%
5Y230.0%10Y118.7%+111.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1,081.9%3.9%+1,078.0%
TTM1,081.9%1.1%+1,080.8%
YOY27.5%5.0%+22.5%
5Y230.0%4.7%+225.3%
10Y118.7%3.4%+115.3%
1.2.2. Operating Ratio

Measures how efficient Megasoft is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 11.42 means that the operating costs are ₹11.42 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Megasoft Limited:

  • The MRQ is 11.422. The company is inefficient in keeping operating costs low. -1
  • The TTM is 11.422. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.422TTM11.4220.000
TTM11.422YOY1.135+10.287
TTM11.4225Y3.073+8.349
5Y3.07310Y1.986+1.087
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4221.388+10.034
TTM11.4221.391+10.031
YOY1.1351.376-0.241
5Y3.0731.407+1.666
10Y1.9861.176+0.810
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Megasoft Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Megasoft is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.54 means the company has ₹2.54 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Megasoft Limited:

  • The MRQ is 2.540. The company is able to pay all its short-term debts. +1
  • The TTM is 2.540. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.540TTM2.5400.000
TTM2.540YOY1.502+1.039
TTM2.5405Y1.089+1.452
5Y1.08910Y0.900+0.188
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5401.866+0.674
TTM2.5401.860+0.680
YOY1.5022.105-0.603
5Y1.0892.367-1.278
10Y0.9002.087-1.187
1.3.2. Quick Ratio

Measures if Megasoft is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.68 means the company can pay off ₹0.68 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Megasoft Limited:

  • The MRQ is 0.676. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.676. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.676TTM0.6760.000
TTM0.676YOY1.260-0.584
TTM0.6765Y0.597+0.079
5Y0.59710Y0.621-0.024
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6760.723-0.047
TTM0.6760.760-0.084
YOY1.2601.065+0.195
5Y0.5971.106-0.509
10Y0.6211.097-0.476
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Megasoft Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Megasoft assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Megasoft to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.49 means that Megasoft assets are financed with 48.7% credit (debt) and the remaining percentage (100% - 48.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Megasoft Limited:

  • The MRQ is 0.487. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.487. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.487TTM0.4870.000
TTM0.487YOY0.355+0.132
TTM0.4875Y0.509-0.022
5Y0.50910Y0.501+0.008
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4870.423+0.064
TTM0.4870.425+0.062
YOY0.3550.391-0.036
5Y0.5090.400+0.109
10Y0.5010.402+0.099
1.4.2. Debt to Equity Ratio

Measures if Megasoft is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 94.9% means that company has ₹0.95 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Megasoft Limited:

  • The MRQ is 0.949. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.949. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.949TTM0.9490.000
TTM0.949YOY0.551+0.398
TTM0.9495Y1.089-0.140
5Y1.08910Y1.043+0.045
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9490.658+0.291
TTM0.9490.681+0.268
YOY0.5510.631-0.080
5Y1.0890.683+0.406
10Y1.0430.708+0.335
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Megasoft Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Megasoft generates.

  • Above 15 is considered overpriced but always compare Megasoft to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of 18.46 means the investor is paying ₹18.46 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Megasoft Limited:

  • The EOD is 40.146. Based on the earnings, the company is overpriced. -1
  • The MRQ is 18.465. Based on the earnings, the company is fair priced.
  • The TTM is 18.465. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD40.146MRQ18.465+21.682
MRQ18.465TTM18.4650.000
TTM18.465YOY82.130-63.665
TTM18.4655Y69.380-50.915
5Y69.38010Y55.719+13.661
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD40.1464.258+35.888
MRQ18.4654.295+14.170
TTM18.4654.845+13.620
YOY82.1306.342+75.788
5Y69.3808.849+60.531
10Y55.71915.206+40.513
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Megasoft Limited:

  • The EOD is 31.815. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 14.633. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.633. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD31.815MRQ14.633+17.182
MRQ14.633TTM14.6330.000
TTM14.633YOY24.770-10.137
TTM14.6335Y7.588+7.045
5Y7.58810Y-14.183+21.771
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD31.815-0.406+32.221
MRQ14.633-1.028+15.661
TTM14.633-1.513+16.146
YOY24.770-2.330+27.100
5Y7.588-1.797+9.385
10Y-14.183-3.547-10.636
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Megasoft is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.84 means the investor is paying ₹0.84 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Megasoft Limited:

  • The EOD is 1.833. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.843. Based on the equity, the company is cheap. +2
  • The TTM is 0.843. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.833MRQ0.843+0.990
MRQ0.843TTM0.8430.000
TTM0.843YOY2.057-1.214
TTM0.8435Y0.809+0.034
5Y0.80910Y0.664+0.145
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.8331.623+0.210
MRQ0.8431.644-0.801
TTM0.8431.642-0.799
YOY2.0572.012+0.045
5Y0.8092.516-1.707
10Y0.6643.233-2.569
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Megasoft Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1971.1970%5.809-79%1.574-24%-0.278+123%
Book Value Per Share--26.20726.2070%25.011+5%21.612+21%21.314+23%
Current Ratio--2.5402.5400%1.502+69%1.089+133%0.900+182%
Debt To Asset Ratio--0.4870.4870%0.355+37%0.509-4%0.501-3%
Debt To Equity Ratio--0.9490.9490%0.551+72%1.089-13%1.043-9%
Dividend Per Share----0%-0%-0%-0%
Eps--1.1971.1970%0.626+91%0.443+170%0.345+247%
Free Cash Flow Per Share--1.5101.5100%2.077-27%0.260+482%1.014+49%
Free Cash Flow To Equity Per Share--13.05613.0560%5.067+158%2.218+489%0.836+1462%
Gross Profit Margin--0.9850.9850%-0.674+168%-3.119+417%-1.329+235%
Intrinsic Value_10Y_max--79.301--------
Intrinsic Value_10Y_min--10.092--------
Intrinsic Value_1Y_max--3.244--------
Intrinsic Value_1Y_min--0.454--------
Intrinsic Value_3Y_max--13.332--------
Intrinsic Value_3Y_min--1.854--------
Intrinsic Value_5Y_max--27.739--------
Intrinsic Value_5Y_min--3.782--------
Market Cap3544648500.000+54%1630317000.0001630317000.0000%3795466500.000-57%1406056200.000+16%1071140400.000+52%
Net Profit Margin--5.8245.8240%0.088+6503%1.192+388%0.608+858%
Operating Margin--10.81910.8190%0.275+3836%2.300+370%1.187+812%
Operating Ratio--11.42211.4220%1.135+906%3.073+272%1.986+475%
Pb Ratio1.833+54%0.8430.8430%2.057-59%0.809+4%0.664+27%
Pe Ratio40.146+54%18.46518.4650%82.130-78%69.380-73%55.719-67%
Price Per Share48.050+54%22.10022.1000%51.450-57%19.060+16%14.520+52%
Price To Free Cash Flow Ratio31.815+54%14.63314.6330%24.770-41%7.588+93%-14.183+197%
Price To Total Gains Ratio40.145+54%18.46418.4640%8.857+108%24.031-23%16.794+10%
Quick Ratio--0.6760.6760%1.260-46%0.597+13%0.621+9%
Return On Assets--0.0300.0300%0.016+89%0.011+174%0.009+256%
Return On Equity--0.0590.0590%0.025+137%0.021+183%0.016+260%
Total Gains Per Share--1.1971.1970%5.809-79%1.574-24%-0.278+123%
Usd Book Value--23199852.00023199852.0000%22140300.000+5%19132202.400+21%18867812.400+23%
Usd Book Value Change Per Share--0.0140.0140%0.070-79%0.019-24%-0.003+123%
Usd Book Value Per Share--0.3140.3140%0.300+5%0.259+21%0.256+23%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0140.0140%0.008+91%0.005+170%0.004+247%
Usd Free Cash Flow--1336956.0001336956.0000%1838712.000-27%229761.600+482%897936.000+49%
Usd Free Cash Flow Per Share--0.0180.0180%0.025-27%0.003+482%0.012+49%
Usd Free Cash Flow To Equity Per Share--0.1570.1570%0.061+158%0.027+489%0.010+1462%
Usd Market Cap42535782.000+54%19563804.00019563804.0000%45545598.000-57%16872674.400+16%12853684.800+52%
Usd Price Per Share0.577+54%0.2650.2650%0.617-57%0.229+16%0.174+52%
Usd Profit--1377408.0001377408.0000%554556.000+148%455738.400+202%336726.000+309%
Usd Revenue--236520.000236520.0000%6287532.000-96%5577014.400-96%7688352.000-97%
Usd Total Gains Per Share--0.0140.0140%0.070-79%0.019-24%-0.003+123%
 EOD+4 -4MRQTTM+0 -0YOY+19 -155Y+24 -1010Y+29 -5

3.2. Fundamental Score

Let's check the fundamental score of Megasoft Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1540.146
Price to Book Ratio (EOD)Between0-11.833
Net Profit Margin (MRQ)Greater than05.824
Operating Margin (MRQ)Greater than010.819
Quick Ratio (MRQ)Greater than10.676
Current Ratio (MRQ)Greater than12.540
Debt to Asset Ratio (MRQ)Less than10.487
Debt to Equity Ratio (MRQ)Less than10.949
Return on Equity (MRQ)Greater than0.150.059
Return on Assets (MRQ)Greater than0.050.030
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Megasoft Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.068
Ma 20Greater thanMa 5050.423
Ma 50Greater thanMa 10048.461
Ma 100Greater thanMa 20045.897
OpenGreater thanClose48.200
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,768,090
Total Liabilities1,834,769
Total Stockholder Equity1,933,321
 As reported
Total Liabilities 1,834,769
Total Stockholder Equity+ 1,933,321
Total Assets = 3,768,090

Assets

Total Assets3,768,090
Total Current Assets589,735
Long-term Assets589,735
Total Current Assets
Cash And Cash Equivalents 22,862
Short-term Investments 67,034
Other Current Assets 89,926
Total Current Assets  (as reported)589,735
Total Current Assets  (calculated)179,822
+/- 409,913
Long-term Assets
Property Plant Equipment 1,791,883
Long-term Assets Other 117,034
Long-term Assets  (as reported)3,178,355
Long-term Assets  (calculated)1,908,917
+/- 1,269,438

Liabilities & Shareholders' Equity

Total Current Liabilities232,136
Long-term Liabilities1,602,633
Total Stockholder Equity1,933,321
Total Current Liabilities
Short-term Debt 77,489
Short Long Term Debt 77,489
Accounts payable 2,493
Other Current Liabilities 152,154
Total Current Liabilities  (as reported)232,136
Total Current Liabilities  (calculated)309,625
+/- 77,489
Long-term Liabilities
Long term Debt Total 1,380,540
Long-term Liabilities Other 22,314
Long-term Liabilities  (as reported)1,602,633
Long-term Liabilities  (calculated)1,402,854
+/- 199,779
Total Stockholder Equity
Common Stock737,700
Other Stockholders Equity 1,195,621
Total Stockholder Equity (as reported)1,933,321
Total Stockholder Equity (calculated)1,933,321
+/-0
Other
Capital Stock737,700
Cash and Short Term Investments 89,896
Common Stock Shares Outstanding 73,579
Liabilities and Stockholders Equity 3,768,090
Net Debt 1,435,167
Net Invested Capital 3,391,350
Net Working Capital 357,599
Short Long Term Debt Total 1,458,029



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-31
> Total Assets 
6,626,214
4,779,705
3,196,588
3,355,642
3,602,547
3,512,986
3,122,452
2,819,150
2,741,001
2,968,297
3,217,459
3,312,629
3,173,280
2,861,488
3,768,090
3,768,0902,861,4883,173,2803,312,6293,217,4592,968,2972,741,0012,819,1503,122,4523,512,9863,602,5473,355,6423,196,5884,779,7056,626,214
   > Total Current Assets 
3,764,196
1,806,040
1,064,264
1,076,034
1,389,596
1,344,639
1,075,224
881,816
869,147
958,478
812,679
865,273
672,995
806,139
589,735
589,735806,139672,995865,273812,679958,478869,147881,8161,075,2241,344,6391,389,5961,076,0341,064,2641,806,0403,764,196
       Cash And Cash Equivalents 
117,386
265,595
79,926
84,669
195,087
102,062
37,630
51,416
11,599
6,154
25,860
58,357
67,909
352,426
22,862
22,862352,42667,90958,35725,8606,15411,59951,41637,630102,062195,08784,66979,926265,595117,386
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
4,490
19,931
67,034
67,03419,9314,490000000000000
       Net Receivables 
0
0
0
0
0
1,190,278
1,020,228
650,119
720,536
849,067
644,751
637,019
332,899
304,316
0
0304,316332,899637,019644,751849,067720,536650,1191,020,2281,190,27800000
       Other Current Assets 
969,705
626,323
489,293
478,968
1,194,509
1,242,577
1,037,594
1
857,548
952,324
786,819
806,916
150,418
38,010
89,926
89,92638,010150,418806,916786,819952,324857,54811,037,5941,242,5771,194,509478,968489,293626,323969,705
   > Long-term Assets 
2,862,018
2,973,665
2,132,324
2,279,608
2,212,951
2,168,347
2,047,229
1,937,334
1,871,854
2,009,819
2,404,789
2,447,356
2,500,285
2,055,349
3,178,355
3,178,3552,055,3492,500,2852,447,3562,404,7892,009,8191,871,8541,937,3342,047,2292,168,3472,212,9512,279,6082,132,3242,973,6652,862,018
       Property Plant Equipment 
1,697,488
1,814,973
995,344
1,050,100
984,157
938,937
830,459
872,185
808,063
929,571
1,545,646
1,587,725
1,639,952
1,865,183
1,791,883
1,791,8831,865,1831,639,9521,587,7251,545,646929,571808,063872,185830,459938,937984,1571,050,100995,3441,814,9731,697,488
       Goodwill 
0
0
0
0
0
1,015,750
1,015,750
1,015,750
1,015,750
1,015,750
793,612
793,612
793,612
175,874
0
0175,874793,612793,612793,6121,015,7501,015,7501,015,7501,015,7501,015,75000000
       Long Term Investments 
0
0
0
0
0
121,230
121,230
0
0
11,352
0
0
0
0
0
0000011,35200121,230121,23000000
       Intangible Assets 
0
0
0
0
0
92,430
79,160
79,160
44,882
41,677
46,205
46,205
46,205
0
0
0046,20546,20546,20541,67744,88279,16079,16092,43000000
       Long-term Assets Other 
121,230
121,230
1,015,750
121,230
121,230
121,230
121,230
-29,761
1,871,854
13,647
13,636
13,739
6,074
21,015
117,034
117,03421,0156,07413,73913,63613,6471,871,854-29,761121,230121,230121,230121,2301,015,750121,230121,230
> Total Liabilities 
2,973,659
2,585,480
1,124,531
1,213,748
1,464,100
1,407,195
1,424,094
1,540,556
1,425,096
1,615,519
1,844,251
1,908,931
1,756,781
1,016,463
1,834,769
1,834,7691,016,4631,756,7811,908,9311,844,2511,615,5191,425,0961,540,5561,424,0941,407,1951,464,1001,213,7481,124,5312,585,4802,973,659
   > Total Current Liabilities 
749,195
613,713
248,210
212,732
1,443,923
1,390,292
1,409,602
1,522,029
1,407,009
1,512,754
1,723,135
1,752,733
1,546,093
536,830
232,136
232,136536,8301,546,0931,752,7331,723,1351,512,7541,407,0091,522,0291,409,6021,390,2921,443,923212,732248,210613,713749,195
       Short-term Debt 
0
0
0
0
1,073,730
720,267
936,344
981,042
459,806
470,447
408,198
401,437
304,285
20,937
77,489
77,48920,937304,285401,437408,198470,447459,806981,042936,344720,2671,073,7300000
       Short Long Term Debt 
0
0
0
0
0
920,489
936,410
981,042
459,806
470,446
408,198
396,465
295,047
10,310
77,489
77,48910,310295,047396,465408,198470,446459,806981,042936,410920,48900000
       Accounts payable 
258,088
390,032
80,858
58,870
170,452
279,265
274,796
318,816
288,927
268,647
147,869
121,062
94,377
189,021
2,493
2,493189,02194,377121,062147,869268,647288,927318,816274,796279,265170,45258,87080,858390,032258,088
       Other Current Liabilities 
491,107
223,681
167,352
153,862
199,741
390,760
198,462
222,171
658,276
773,660
1,167,068
4,006
5,192
326,872
152,154
152,154326,8725,1924,0061,167,068773,660658,276222,171198,462390,760199,741153,862167,352223,681491,107
   > Long-term Liabilities 
2,224,464
1,971,767
876,321
1,001,016
20,177
16,903
14,492
18,527
18,087
102,765
121,116
156,198
210,688
479,633
1,602,633
1,602,633479,633210,688156,198121,116102,76518,08718,52714,49216,90320,1771,001,016876,3211,971,7672,224,464
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
40,273
269,388
1,380,540
1,380,540269,38840,273000000000000
       Other Liabilities 
0
0
0
0
0
15,841
14,426
18,527
104,656
102,765
121,118
156,199
210,686
210,246
0
0210,246210,686156,199121,118102,765104,65618,52714,42615,84100000
> Total Stockholder Equity
3,652,555
2,194,225
2,072,057
2,141,894
2,138,447
2,105,791
1,698,358
1,278,594
1,315,905
1,352,778
1,373,208
1,403,698
1,416,499
1,845,025
1,933,321
1,933,3211,845,0251,416,4991,403,6981,373,2081,352,7781,315,9051,278,5941,698,3582,105,7912,138,4472,141,8942,072,0572,194,2253,652,555
   Common Stock
442,673
442,673
442,673
442,673
442,673
442,673
442,673
442,673
442,673
442,673
442,673
442,673
442,673
737,700
737,700
737,700737,700442,673442,673442,673442,673442,673442,673442,673442,673442,673442,673442,673442,673442,673
   Retained Earnings 
0
0
1,109,951
1,284,869
0
1,323,315
932,221
789,845
816,508
836,760
837,209
844,280
862,761
686,837
1,195,621
1,195,621686,837862,761844,280837,209836,760816,508789,845932,2211,323,31501,284,8691,109,95100
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
3,209,882
1,751,552
519,433
414,352
1,695,774
339,803
323,464
46,076
56,724
73,345
93,326
116,745
111,065
420,488
1,195,621
1,195,621420,488111,065116,74593,32673,34556,72446,076323,464339,8031,695,774414,352519,4331,751,5523,209,882



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.